Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bile Duct Neoplasms × Pemetrexed × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 209 Lung Neoplasms 74 Neoplasms 24 Adenocarcinoma of Lung 16 Neoplasm Metastasis 15 Mesothelioma, Malignant 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Mesothelioma 12 Carcinoma 11 Head and Neck Neoplasms 10 Breast Neoplasms 8 Adenocarcinoma, Bronchiolo-Alveolar 7 Small Cell Lung Carcinoma 6 Recurrence 5 Ovarian Neoplasms 5 Colorectal Neoplasms 4 Adenocarcinoma 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Pancreatic Neoplasms 3 Lung Diseases 3 Laryngeal Diseases 3 Carcinoma, Small Cell 3 Brain Neoplasms 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Thoracic Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Respiratory Tract Neoplasms 2

Interventions

Gemcitabine 12 Capecitabine 8 Cisplatin 7 pembrolizumab 4 Fluorouracil 4 Sorafenib 3 Oxaliplatin 3 Erlotinib Hydrochloride 3 trametinib 2 regorafenib 2 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2 Leucovorin 2 Lapatinib 2 trifluridine tipiracil drug combination 1 tremelimumab 1 spartalizumab 1 seribantumab 1 olutasidenib 1 durvalumab 1 devimistat 1 derazantinib 1 dehydroftorafur 1 cediranib 1 cabozantinib 1 Trifluridine 1 Trastuzumab 1 Therapeutics 1 Sutures 1 Surgical Instruments 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡